{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:18:35Z","timestamp":1781770715581,"version":"3.54.5"},"reference-count":50,"publisher":"Frontiers Media SA","issue":"1","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Fondazione Compagnia San Paolo"},{"name":"IRCCS G. Gaslini","award":["progetti Ricerca Corrente"],"award-info":[{"award-number":["progetti Ricerca Corrente"]}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","award":["progetti Ricerca Corrente"],"award-info":[{"award-number":["progetti Ricerca Corrente"]}],"id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Malattie Renali del Bambino"},{"name":"Programma Ricerca Trapianti"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/tri.13325","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T06:47:10Z","timestamp":1533624430000},"page":"38-48","source":"Crossref","is-referenced-by-count":15,"title":["Failure to remove<i>de novo<\/i>donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study"],"prefix":"10.3389","volume":"32","author":[{"given":"Michela","family":"Cioni","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Nephrology; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Nocera","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Tagliamacco","sequence":"additional","affiliation":[{"name":"Clinical Nephrology Unit and Transplant Coordination Unit; Policlinico San Martino; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Basso","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology & Cell Factory; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Innocente","sequence":"additional","affiliation":[{"name":"Transplantation Immunology; Fondazione Ca\u2019 Granda; Ospedale Maggiore Policlinico; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Fontana","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Unit and Kidney Transplant Surgery Unit; Policlinico San Martino; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Magnasco","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Trivelli","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Klersy","sequence":"additional","affiliation":[{"name":"Biometry and Statistics Service; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Gurrado","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology & Cell Factory; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Ramondetta","sequence":"additional","affiliation":[{"name":"Transplantation Immunology; Fondazione Ca\u2019 Granda; Ospedale Maggiore Policlinico; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Boghen","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology & Cell Factory; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Catenacci","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology & Cell Factory; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Verrina","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Garibotto","sequence":"additional","affiliation":[{"name":"Clinical Nephrology Unit; University of Genova and Policlinico San Martino; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cardillo","sequence":"additional","affiliation":[{"name":"Transplantation Immunology; Fondazione Ca\u2019 Granda; Ospedale Maggiore Policlinico; Milano Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2377-8774","authenticated-orcid":false,"given":"Fabrizio","family":"Ginevri","sequence":"additional","affiliation":[{"name":"Nephrology, Dialysis, Transplantation Unit; IRCCS Istituto Giannina Gaslini; Genova Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Comoli","sequence":"additional","affiliation":[{"name":"Pediatric Hematology\/Oncology & Cell Factory; Fondazione IRCCS Policlinico S. Matteo; Pavia Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"10.1111\/tri.13325-BIB0001|tri13325-cit-0001","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/TP.0b013e3181b11b72","article-title":"HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss","volume":"88","author":"Lee","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0002|tri13325-cit-0002","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/j.1600-6143.2009.02800.x","article-title":"De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure","volume":"9","author":"Hidalgo","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0003|tri13325-cit-0003","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/tri.13325-BIB0004|tri13325-cit-0004","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1600-6143.2008.02441.x","article-title":"Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation","volume":"8","author":"Burns","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0005|tri13325-cit-0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2009101065","article-title":"Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation","volume":"21","author":"Lefaucheur","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0006|tri13325-cit-0006","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0007|tri13325-cit-0007","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/j.1600-6143.2012.04251.x","article-title":"Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection","volume":"12","author":"Ginevri","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0008|tri13325-cit-0008","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0009|tri13325-cit-0009","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/ajt.12859","article-title":"The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0010|tri13325-cit-0010","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/01.tp.0000288807.52520.5e","article-title":"C4d-positive chronic rejection: a frequent entity with a poor outcome","volume":"84","author":"David-Neto","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0011|tri13325-cit-0011","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0012|tri13325-cit-0012","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ajt.12589","article-title":"Diagnosis and management of antibody-mediated rejection: current status and novel approaches","volume":"14","author":"Djamali","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0013|tri13325-cit-0013","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/ajt.14528","article-title":"Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection - results from a first-in-patient phase 1 trial","volume":"18","author":"Eskandary","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0014|tri13325-cit-0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.trre.2016.10.004","article-title":"Acute antibody-mediated rejection in kidney transplant recipients","volume":"31","author":"Davis","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1111\/tri.13325-BIB0015|tri13325-cit-0015","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0b013e3181a6bac5","article-title":"Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection","volume":"87","author":"Fehr","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0016|tri13325-cit-0016","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TP.0b013e31824612df","article-title":"Durability of antibody removal following proteasome inhibitor-based therapy","volume":"93","author":"Everly","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0017|tri13325-cit-0017","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1432-2277.2012.01544.x","article-title":"IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up","volume":"25","author":"Billing","year":"2012","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13325-BIB0018|tri13325-cit-0018","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.humimm.2016.01.018","article-title":"Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria","volume":"77","author":"Redfield","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13325-BIB0019|tri13325-cit-0019","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/ajt.14001","article-title":"Eculizumab therapy for chronic antibody-mediated injury in kidney transplant recipients: a pilot randomized controlled trial","volume":"17","author":"Kulkarni","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0020|tri13325-cit-0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1681\/ASN.2014111120","article-title":"IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury","volume":"27","author":"Lefaucheur","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0021|tri13325-cit-0021","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2012.190","article-title":"Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation","volume":"82","author":"DeVos","year":"2012","journal-title":"Kidney Int"},{"key":"10.1111\/tri.13325-BIB0022|tri13325-cit-0022","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/tri.12316","article-title":"DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant","volume":"27","author":"Tagliamacco","year":"2014","journal-title":"Transpl Int"},{"key":"10.1111\/tri.13325-BIB0023|tri13325-cit-0023","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0024|tri13325-cit-0024","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2016030368","article-title":"Value of donor-specific anti-HLA antibody monitoring and characterization for risk stratification of kidney allograft loss","volume":"28","author":"Viglietti","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0025|tri13325-cit-0025","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.13325-BIB0026|tri13325-cit-0026","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2013101144","article-title":"Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss","volume":"26","author":"Sicard","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0027|tri13325-cit-0027","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/ajt.13700","article-title":"Acquisition of C3d-binding activity by de novo donor-specific HLA antibodies correlates with graft loss in nonsensitized pediatric kidney recipients","volume":"16","author":"Comoli","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0028|tri13325-cit-0028","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/ajt.12438","article-title":"Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome","volume":"13","author":"Bachelet","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0029|tri13325-cit-0029","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/ajt.14000","article-title":"Kidney intragraft homing of de novo donor-specific HLA antibodies is an essential step of antibody-mediated damage but not per se predictive of graft loss","volume":"17","author":"Nocera","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0030|tri13325-cit-0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/TP.0b013e3181cbac02","article-title":"Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection","volume":"89","author":"Everly","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0031|tri13325-cit-0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.humimm.2016.11.009","article-title":"Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation","volume":"78","author":"Ramon","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13325-BIB0032|tri13325-cit-0032","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2017070749","article-title":"Dynamic prognostic score to predict kidney allograft survival in patients with antibody-mediated rejection","volume":"29","author":"Viglietti","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0033|tri13325-cit-0033","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0034|tri13325-cit-0034","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/tri.13325-BIB0035|tri13325-cit-0035","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.ajkd.2014.01.436","article-title":"Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients","volume":"63","author":"Shaffi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/tri.13325-BIB0036|tri13325-cit-0036","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000000525","article-title":"Factors predicting risk for antibody-mediated rejection and graft loss in highly human leukocyte antigen sensitized patients transplanted after desensitization","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0037|tri13325-cit-0037","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/01.TP.0000442503.85766.91","article-title":"Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies","volume":"97","author":"Gupta","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0038|tri13325-cit-0038","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trim.2012.08.005","article-title":"Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts","volume":"27","author":"Smith","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1111\/tri.13325-BIB0039|tri13325-cit-0039","doi-asserted-by":"crossref","first-page":"e12873","DOI":"10.1111\/petr.12873","article-title":"Bortezomib in the treatment of antibody-mediated rejection in pediatric kidney transplant recipients: a multicenter Midwest Pediatric Nephrology Consortium study","volume":"21","author":"Kizilbash","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1111\/tri.13325-BIB0040|tri13325-cit-0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/ajt.12982","article-title":"Quantifying renal allograft loss following early antibody-mediated rejection","volume":"15","author":"Orandi","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0041|tri13325-cit-0041","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.humimm.2016.05.025","article-title":"Can solid phase assays be better utilized to measure efficacy of antibody removal therapies?","volume":"77","author":"Tambur","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1111\/tri.13325-BIB0042|tri13325-cit-0042","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0043|tri13325-cit-0043","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/trf.12923","article-title":"Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients","volume":"55","author":"Yamada","year":"2015","journal-title":"Transfusion"},{"key":"10.1111\/tri.13325-BIB0044|tri13325-cit-0044","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/phar.1426","article-title":"Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options","volume":"34","author":"Kim","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1111\/tri.13325-BIB0045|tri13325-cit-0045","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/TP.0b013e318286191b","article-title":"Plasmapheresis adjusts inflammatory responses in potential kidney transplant recipients","volume":"95","author":"Sadeghi","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/tri.13325-BIB0046|tri13325-cit-0046","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00467-017-3772-7","article-title":"Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies","volume":"33","author":"Kim","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/tri.13325-BIB0047|tri13325-cit-0047","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.trim.2015.06.002","article-title":"Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy","volume":"33","author":"Messina","year":"2015","journal-title":"Transpl Immunol"},{"key":"10.1111\/tri.13325-BIB0048|tri13325-cit-0048","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/ajt.14015","article-title":"Evaluation of C1q status and titer of de novo donor-specific antibodies as predictors of allograft survival","volume":"17","author":"Wiebe","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.13325-BIB0049|tri13325-cit-0049","doi-asserted-by":"crossref","first-page":"5201098","DOI":"10.1155\/2017\/5201098","article-title":"From humoral theory to performant risk stratification in kidney transplantation","volume":"2017","author":"Lefaucheur","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1111\/tri.13325-BIB0050|tri13325-cit-0050","doi-asserted-by":"crossref","first-page":"e0178572","DOI":"10.1371\/journal.pone.0178572","article-title":"Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: results of an observational study","volume":"12","author":"Matignon","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.13325","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.13325\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:41:15Z","timestamp":1641062475000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.13325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.13325","archive":["Portico"],"relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,27]]}}}